HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
Clinical trial NCT02239952 · UNKNOWN
Trial details
- NCT number
- NCT02239952
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2021-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.